Novus Cannabis MedPlans is Well-Received at Major ICMG Insurance Conference
Novus Reports Second Quarter 2021 Results
Market Changes Gather Interest From Carriers and Wholesalers, Prompting Distribution Agreements To A Larger Target AudienceMIAMI, FL / ACCESSWIRE / February 9, 2022 / Novus Acquisition and Development, Corp. (OTC PINK:NDEV), through its wholly-owned subsidiary WCIG Insurance Services, Inc.
Novus Signs Partnership With PRAM, a Leading Pharmacy Consulting, and Underwriting Firm
Signs First Oklahoma Provider and Continued Execution of Carrier AgreementsMIAMI, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Novus Acquisition and Development, Corp.
Novus Reports First Quarter 2021 Results
Proud to be Aligned with a Proprietary Prescription Drug Benefits Powerhouse As We Begin Our Roll Out To Their Distribution BaseMIAMI, FL / ACCESSWIRE / July 19, 2021 / Novus Acquisition and Development, Corp. (OTC PINK:NDEV), through its wholly-owned subsidiary WCIG Insurance Services, LLC.
Novus 2020 Annual Report Shows Continual Expansion
Continued Ramping of Prominent Insurance Distributors Leads to GrowthMIAMI, FL / ACCESSWIRE / May 18, 2021 / Novus Acquisition and Development, Corp. (OTC PINK:NDEV), through its wholly-owned subsidiary WCIG Insurance Services, LLC.
About Nova Vision Acquisition
Agreements with Carriers and InsureTech Platform Continue to Increase Visibility and TractionMIAMI, FL / ACCESSWIRE / March 30, 2021 / Novus Acquisition and Development, Corp. (OTC PINK:NDEV), through its wholly-owned subsidiary WCIG Insurance Services, Inc.
0.0 Analyst's Opinion
Nova Vision Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. Nova Vision Acquisition Corp. is based in Singapore.
Are investors shorting Nova Vision Acquisition?
Nova Vision Acquisition has received 0 “outperform” votes. (Add your “outperform” vote.)
When is Nova Vision Acquisition's next earnings date?
Nova Vision Acquisition saw a increase in short interest in January. As of January 15th, there was short interest totaling 6,400 shares, an increase of 77.8% from the December 31st total of 3,600 shares. Based on an average trading volume of 11,100 shares, the short-interest ratio is presently 0.6 days.
How were Nova Vision Acquisition's earnings last quarter?
Nova Vision Acquisition is scheduled to release its next quarterly earnings announcement on Friday, February 11th 2022. View our earnings forecast for Nova Vision Acquisition.
Who are some of Nova Vision Acquisition's key competitors?
Nova Vision Acquisition Corp (NASDAQ:NOVV) posted its quarterly earnings data on Friday, November, 12th. The company reported ($0.10) EPS for the quarter. View Nova Vision Acquisition's earnings history.
What is Nova Vision Acquisition's stock symbol?
Some companies that are related to Nova Vision Acquisition include Anthemis Digital Acquisitions I (ADAL), Vickers Vantage Corp.
What is Novartis AG?
Nova Vision Acquisition trades on the NASDAQ under the ticker symbol "NOVV."
Does market cap include convertible securities?
Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The firm sells its products globally, with the United States representing close to one third of total revenue.
